| Literature DB >> 21279158 |
José Vassallo, Talal Al Saati, Randy D Gascoyne, Kathyrn Welsh, John C Reed, Pierre Brousset, Georges Delsol.
Abstract
Survivin is a member of the inhibitor of apoptosis gene family, which is also implicated in mitosis regulation. Most reports in the literature impute poor prognosis to neoplasms with overexpression of this protein. The purpose of the present study is to validate and compare the immunohistochemical reactivity of malignant lymphomas and reactive lymphoid tissue using a new mouse monoclonal antibody to Survivin produced in our laboratory, 6-78. Survivin was detected by immunohistochemistry on tissue microarrays. It was shown that the antibody anti-Survivin 6-78 reliably stains formalin-fixed, paraffin-embedded reactive and neoplastic lymphoid tissues, mostly in a nuclear pattern. We confirmed using this novel antibody that Survivin immunostaining has a tendency to be lower in reactive lymphoid tissues and low-grade B cell lymphomas than in aggressive lymphomas. This antibody may represent a useful tool for standardizing the study of the immunoexpression of Survivin in neoplasms.Entities:
Keywords: Immunohistochemistry; Malignant lymphomas; Mouse monoclonal antibody 6-78; Survivin
Year: 2010 PMID: 21279158 PMCID: PMC2883904 DOI: 10.1007/s12308-009-0054-8
Source DB: PubMed Journal: J Hematop ISSN: 1865-5785 Impact factor: 0.196